Drug Shortage Report for VIBERZI
| Report ID | 168065 |
| Drug Identification Number | 02460904 |
| Brand name | VIBERZI |
| Common or Proper name | Viberzi (Eluxadoline Tablets) |
| Company Name | ABBVIE CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | ELUXADOLINE |
| Strength(s) | 100MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 60s |
| ATC code | A07DA |
| ATC description | |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2022-09-30 |
| Actual start date | |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2023-03-17 |
| Company comments | Added to the List of Drugs for Exceptional Importation and Sale |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 8401 TRANS-CANADA HIGHWAY SAINT-LAURENT, QUEBEC CANADA H4S 1Z1 |
| Company contact information | Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-03-17 | French | Compare |
| v5 | 2023-03-17 | English | Compare |
| v4 | 2022-10-01 | English | Compare |
| v3 | 2022-09-22 | English | Compare |
| v2 | 2022-08-26 | French | Compare |
| v1 | 2022-08-26 | English | Compare |
Showing 1 to 6 of 6